MYDA Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-50,000
Closed -$497K 114
2019
Q1
$497K Buy
50,000
+35,000
+233% +$348K 0.25% 41
2018
Q4
$115K Buy
15,000
+4,000
+36% +$30.7K 0.2% 37
2018
Q3
$192K Buy
+11,000
New +$192K 0.1% 87